Jozef Madzo to Humans
This is a "connection" page, showing publications Jozef Madzo has written about Humans.
Connection Strength
0.265
-
DREAM: A Simple Method for DNA Methylation Profiling by High-throughput Sequencing. Methods Mol Biol. 2016; 1465:111-27.
Score: 0.018
-
Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis. Cell Rep. 2014 Jan 16; 6(1):231-244.
Score: 0.016
-
Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies. Semin Hematol. 2013 Jan; 50(1):61-9.
Score: 0.015
-
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD. Blood. 2024 Jan 11; 143(2):166-177.
Score: 0.008
-
Postmortem toxicology findings from the Camden Opioid Research Initiative. PLoS One. 2023; 18(11):e0292674.
Score: 0.008
-
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer. mBio. 2023 Oct 31; 14(5):e0039623.
Score: 0.008
-
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clin Cancer Res. 2023 06 01; 29(11):2052-2065.
Score: 0.008
-
Promoter-independent synthesis of chemically modified RNA by human DNA polymerase ? variants. RNA. 2023 08; 29(8):1288-1300.
Score: 0.008
-
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias. Blood Cancer J. 2023 03 23; 13(1):42.
Score: 0.008
-
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype. Gastroenterology. 2023 05; 164(6):921-936.e1.
Score: 0.007
-
Novel treatment strategy of targeting epigenetic dysregulation in pancreatic neuroendocrine tumors. Surgery. 2023 04; 173(4):1045-1051.
Score: 0.007
-
Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study. Cancer. 2003 Jan 01; 97(1):105-13.
Score: 0.007
-
Single cell transcriptomic analysis reveals cellular diversity of murine esophageal epithelium. Nat Commun. 2022 04 20; 13(1):2167.
Score: 0.007
-
The nuclear lamina binds the EBV genome during latency and regulates viral gene expression. PLoS Pathog. 2022 04; 18(4):e1010400.
Score: 0.007
-
Transcriptome-guided resolution of tumor microenvironment interactions in pheochromocytoma and paraganglioma subtypes. J Endocrinol Invest. 2022 May; 45(5):989-998.
Score: 0.007
-
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity. Nat Commun. 2022 01 17; 13(1):187.
Score: 0.007
-
TET2 and DNMT3A Mutations Exert Divergent Effects on DNA Repair and Sensitivity of Leukemia Cells to PARP Inhibitors. Cancer Res. 2021 10 01; 81(19):5089-5101.
Score: 0.007
-
Accelerated aging in normal breast tissue of women with breast cancer. Breast Cancer Res. 2021 05 22; 23(1):58.
Score: 0.007
-
The developmental origins of sex-biased expression in cardiac development. Biol Sex Differ. 2019 09 05; 10(1):46.
Score: 0.006
-
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1. PLoS Pathog. 2018 11; 14(11):e1007394.
Score: 0.006
-
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer. Cell. 2018 11 15; 175(5):1244-1258.e26.
Score: 0.006
-
PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type. J Virol. 2018 09 15; 92(18).
Score: 0.005
-
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer. Cancer Res. 2018 08 01; 78(15):4126-4137.
Score: 0.005
-
Demethylator phenotypes in acute myeloid leukemia. Leukemia. 2018 10; 32(10):2178-2188.
Score: 0.005
-
Digital Restriction Enzyme Analysis of Methylation (DREAM). Methods Mol Biol. 2018; 1708:247-265.
Score: 0.005
-
Caloric restriction delays age-related methylation drift. Nat Commun. 2017 09 14; 8(1):539.
Score: 0.005
-
A novel isoform of TET1 that lacks a CXXC domain is overexpressed in cancer. Nucleic Acids Res. 2017 Aug 21; 45(14):8269-8281.
Score: 0.005
-
Transcriptional Selectivity of Epigenetic Therapy in Cancer. Cancer Res. 2017 01 15; 77(2):470-481.
Score: 0.005
-
TET-catalyzed 5-hydroxymethylcytosine regulates gene expression in differentiating colonocytes and colon cancer. Sci Rep. 2015 Dec 03; 5:17568.
Score: 0.005
-
TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia. Cancer Res. 2015 Jul 15; 75(14):2833-43.
Score: 0.004
-
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
Score: 0.004
-
DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep. 2014 Dec 11; 9(5):1841-1855.
Score: 0.004
-
TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma. Cell Rep. 2014 Jun 12; 7(5):1343-1352.
Score: 0.004
-
Identifying familial myelodysplastic/acute leukemia predisposition syndromes through hematopoietic stem cell transplantation donors with thrombocytopenia. Blood. 2012 Dec 20; 120(26):5247-9.
Score: 0.004
-
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell. 2011 Jul 12; 20(1):11-24.
Score: 0.003
-
ETV6/RUNX1 (TEL/AML1) is a frequent prenatal first hit in childhood leukemia. Blood. 2011 Jan 06; 117(1):368-9; author reply 370-1.
Score: 0.003
-
Revealing the role of TEL/AML1 for leukemic cell survival by RNAi-mediated silencing. Leukemia. 2011 Feb; 25(2):313-20.
Score: 0.003
-
Identification and molecular characterization of a novel 3′ mutation in RUNX1 in a family with familial platelet disorder. Leuk Lymphoma. 2010 Oct; 51(10):1931-5.
Score: 0.003
-
The identification of (ETV6)/RUNX1-regulated genes in lymphopoiesis using histone deacetylase inhibitors in ETV6/RUNX1-positive lymphoid leukemic cells. Clin Cancer Res. 2007 Mar 15; 13(6):1726-35.
Score: 0.002
-
Prenatal origin of childhood AML occurs less frequently than in childhood ALL. BMC Cancer. 2006 Apr 21; 6:100.
Score: 0.002
-
TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL. Leukemia. 2005 Jul; 19(7):1296-7.
Score: 0.002
-
Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens. BMC Cancer. 2005 Apr 12; 5:38.
Score: 0.002
-
TEL/AML1 and immunoreceptor gene rearrangements-which comes first? Leuk Res. 2005 Jun; 29(6):633-9.
Score: 0.002
-
Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. Leukemia. 2004 Mar; 18(3):434-41.
Score: 0.002
-
Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia. 2002 Jul; 16(7):1381-9.
Score: 0.002